Jeffrey Alan Jones Cullinan Oncology, Inc. (CGEM) insider trading activity

Jeffrey Alan Jones is Chief Medical Officer of Cullinan Oncology, Inc.. Currently has a direct ownership of 118,691 shares of CGEM, which is worth approximately $1.49 Million. The most recent transaction as insider was on Feb 22, 2024, when has been sold 62,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 119K

0% 3M change

103.11% 12M change

Total Value Held $1.49 Million

Jeffrey Alan Jones Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2024	BUY Grant, award, or other acquisition	-	62,500 Added 34.49%	118,691 Common Stock
Dec 21 2023	SELL Open market or private sale	$15,810 $8.5 p/Share	1,860 Reduced 3.2%	56,191 Common Stock
Dec 18 2023	SELL Open market or private sale	$3,172 $8.22 p/Share	386 Reduced 0.66%	58,051 Common Stock
Jun 20 2023	SELL Open market or private sale	$5,007 $12.94 p/Share	387 Reduced 0.66%	58,437 Common Stock
May 18 2023	SELL Open market or private sale	$3,451 $8.76 p/Share	394 Reduced 0.67%	58,824 Common Stock
Apr 18 2023	SELL Open market or private sale	$4,198 $10.71 p/Share	392 Reduced 0.66%	59,218 Common Stock
Mar 20 2023	SELL Open market or private sale	$4,414 $11.32 p/Share	390 Reduced 0.65%	59,610 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	-	60,000 Added 50.0%	60,000 Common Stock

JAJ

Jeffrey Alan Jones

Chief Medical Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Value

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cullinan Oncology, Inc.

Track Activities on CGEM

Account